Saturday 17 October 2026
Export LGMK’s income statement to Excel — free account
LogicMark, Inc.
LGMK Healthcare Health Information Services
LogicMark, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.4 million, up 15.4% from fiscal 2024. In the quarter to June 2026, revenue grew 17.4%, EPS grew 35.4% and free cash flow grew 96.4%, each against the same quarter a year earlier.
1.30
0.10
+8.33%
Follow LGMK
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.04 | 0.04 | 0.04 | 0.16 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
6.16 | (0.30) | (0.25) | (2.28) | |
P/B ratio |
0.04 | 0.03 | 0.03 | 0.10 | |
Price to Tangible BV |
0.06 | 0.05 | 0.04 | 0.14 | |
EV/Sales |
(0.16) | (0.24) | (0.44) | (0.56) | |
EV/EBITDA |
0.49 | 0.61 | 0.87 | 0.91 | |
EV/Operating CF |
0.52 | 0.58 | 0.99 | 1.33 | |
EV/FCF |
0.11 | 0.14 | 0.25 | 0.30 | |
Quick Ratio |
3.73 | 4.71 | 4.93 | 4.86 | |
Current Ratio |
4.88 | 6.30 | 6.00 | 5.61 | |
Net Debt/EBITDA |
6.75 | 8.51 | 8.91 | 9.49 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.62 | 0.55 | 0.66 | 0.55 | |
Operating CF/Net income |
(0.05) | 1.08 | 0.98 | 0.45 | |
Capex/Depreciation |
(0.69) | (0.48) | (0.55) | (0.85) | |
Research and Development Expense of Revenue |
2.73% | 3.84% | 5.29% | 5.54% | |
Selling, General and Administrative Expense of Revenue |
85.87% | 81.28% | 86.45% | 89.44% | |
Intangible Assets out of Total Assets |
0.25 | 0.24 | 0.22 | 0.21 | |
Share Based Compensation of Revenue |
12.89% | 2.48% | 8.85% | 4.76% | |
Graham Net Nets |
9.42 | 13.00 | 18.19 | 5.20 | |
Graham Number |
0.00 | 0.00 | 0.00 | 3,675.52 | |
Earnings Yield |
(1,343.86%) | (1,601.91%) | (14,182.61%) | 1,170,687.19% | |
Free Cash Flow Yield |
(3,778.81%) | (4,199.34%) | (4,904.67%) | (1,148.55%) | |
Revenue per Share |
3.72 | 3.55 | 5.15 | 3.79 | |
Operating CF per Share |
0.09 | (1.82) | (2.76) | (0.99) | |
Capex per Share |
(0.47) | (0.33) | (0.56) | (0.56) | |
Free Cash Flow per Share |
(0.38) | (2.15) | (3.31) | (1.55) | |
Cash per Share |
7.37 | 8.26 | 15.99 | 15.21 | |
Shareholders Equity per Share |
14.66 | 16.38 | 27.37 | 23.21 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
14.66 | 16.38 | 27.37 | 23.21 | |
Free Cash Flow |
(0.34) | (1.95) | (1.97) | (1.19) | |
Working Capital |
6.89 | 8.44 | 9.67 | 11.11 | |
Capital Expenditures |
(0.42) | (0.30) | (0.33) | (0.43) | |
Net Current Asset Value |
4.83 | 6.36 | 7.58 | 8.98 | |
EV/EBIT |
0.32 | 0.42 | 0.64 | 0.70 | |
Capex to Sales |
0.13 | 0.09 | 0.11 | 0.15 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.08 | 0.12 | 0.01 | 0.06 | |
Average Payables |
0.54 | 0.65 | 0.66 | 0.60 | |
Average Inventory |
0.99 | 1.27 | 1.22 | 0.93 | |
Average Assets |
20.24 | 21.86 | 17.26 | 19.21 | |
Average Common Equity |
16.14 | 17.70 | 12.78 | 14.78 |
Columns are period end dates